Morgan Stanley: EDA Duopoly Synopsys and Cadence May Become New Anchor Points for AI Computing Capital
nashnova research
Morgan Stanley maintains Overweight on both EDA leaders Synopsys and Cadence, with target prices implying ~25% upside — This means → Wall Street is re-pricing 'the tools that design chips' as infrastructure-grade assets in the AI compute chain.
Why is Morgan Stanley bullish on "the mother of all chips" now?
The Philadelphia Semiconductor Index just snapped an eight-session losing streak. Morgan Stanley's team tagged Synopsys (SNPS) and Cadence (CDNS) as key investment leads under the AI compute theme, maintaining Overweight on both.
Synopsys target price raised from $500 to $574, implying ~26.3% upside from its $454.63 close. Cadence target held at $400, implying ~25.2% upside from $319.51.
This means → amid broad semiconductor pressure, Morgan Stanley sees EDA — Electronic Design Automation, the software that turns chip blueprints into manufacturable designs — as one of the few lanes with both defensive resilience and AI-driven upside.
What makes EDA both defensive and offensive?
Defense: EDA revenue runs on multi-year contracts and recurring income. It does not swing with near-term chip shipments or memory spot prices. In plain terms = when the chip market cools, selling "the drafting tools" holds up better than selling chips themselves.
Offense: Agentic AI — AI systems that execute multi-step tasks autonomously — is expanding demand for custom AI chip design while also automating the design, verification, and simulation workflows, broadening EDA tool usage.
This means → EDA can charge by usage, converting new AI workloads directly into revenue. Layered on top of the stable licensing base, this creates dual potential for earnings growth and valuation re-rating.
What is the growth case for Synopsys?
Synopsys laid out three AI paths: a full-stack solution, customer-owned platforms with agents, and frontier models. Management raised long-term growth expectations for EDA and design IP to the mid-teens and high-teens, respectively.
Morgan Stanley's FY2027 assumptions: EDA growth 13%, IP growth 15%, simulation growth 9%. Projected FY2027 revenue of $10.896 billion and adjusted EPS of $19.12 — roughly 6.5% above prior estimates. FY2028 EPS climbs to $23.14.
The $574 target uses ~30× FY2027 earnings, still below the five-year average forward P/E of 36×. This reflects Morgan Stanley's view that the valuation gap has room to close. Bull-case target: $1,000; bear case: $200.
How does Cadence's rhythm differ?
Morgan Stanley forecasts Cadence Q3 revenue of $1.612 billion, adjusted EPS of $2.07, and backlog of $8.2 billion. Q4 EPS is projected at $2.10, roughly 3% above consensus.
Last quarter IP grew 40% and hardware hit a record. Design-process co-optimization with Intel, Samsung, and TSMC continues to support EDA demand. ChipStack has over 20 customer engagements, spanning digital verification, analog design, signoff, and advanced packaging.
In plain terms = Cadence's existing business is already solid, but the meaningful earnings lift from AI agents is not expected until 2027 — current guidance does not yet factor it in.
What is the market waiting to verify?
Morgan Stanley states clearly: the next re-rating for the EDA duopoly requires "AI agent adoption → large-scale commercialization → earnings contribution" to materialize. That path is still in its early stages.
Cadence posted record bookings last quarter, yet its stock was essentially flat the next day — the October 26 earnings call needs to spell out the commercialization roadmap. This reflects a market no longer satisfied with order numbers; it wants to see AI value hit the income statement.
This means → for both companies, the October and December earnings seasons are the shared valuation-verification moment: the storytelling phase is ending, and the market wants numbers.
市场有风险，内容仅供研究参考，不构成投资建议。